ABBO News

Uk Watchdog Says It May Accept Remedies in  Billion Synopsys ansys Deal

UK Watchdog Says It May Accept Remedies in $35 Billion Synopsys-Ansys Deal

On Wednesday, the UK’s competition regulator said it might accept remedies offered by chip design software maker Synopsys (NASDAQ: SNPS) and Ansys (NASDAQ: ANSS) to address the concerns raised over their $35 billion deal.

Synopsys announced its cash-and-stock deal for Ansys, whose software is used to make products ranging from airplanes to tennis rackets, in January last year.

The Competition and Markets Authority said the undertakings offered on December 31 included the divestment of Ansys’ power consumption analysis product for digital chips and Synopsys’ sale of its global optics and photonics software business.

The CMA said it has until March 5 to decide whether to accept the undertakings, with the possibility to extend the deadline to May 6.

A Synopsys spokesperson said the companies are pleased with the regulator’s decision, adding that the duo will maintain its “constructive and collaborative engagement” with the CMA.

author avatar
Maria Reed
Maria Reed is a financial journalist with a passion for covering US equities. She joined the ABBO News team in June 2023. Maria holds an M.S. degree in International Economics and Finance from Otto-von-Guericke University in Magdeburg and is a CFA Level 2 candidate.